Phase II trial of piroxantrone in advanced non-small cell carcinoma of the lung. A Southwest Oncology Group study

Invest New Drugs. 1992 Apr;10(1):29-30. doi: 10.1007/BF01275476.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Anthraquinones / administration & dosage*
  • Anthraquinones / adverse effects
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / adverse effects
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Drug Evaluation
  • Female
  • Humans
  • Lung Neoplasms / drug therapy*
  • Male
  • Middle Aged
  • Pyrazoles / administration & dosage*
  • Pyrazoles / adverse effects

Substances

  • Anthraquinones
  • Antineoplastic Agents
  • Pyrazoles
  • piroxantrone